| Politician | Action | Description | Traded |
|---|---|---|---|
| Sell | ALNYLAM THERAPEUTICS | May 15, 2026 | |
| Buy | ALNYLAM PHARMACEUTICALS INCO | Jan 26, 2026 | |
| Sell | ALNYLAM PHARMACEUTICALS | Oct 30, 2025 | |
| Sell | Alnylam Pharmaceuticals, Inc | May 12, 2025 | |
| Buy | ALNYLAM PHARMACEUTICALS, INC | Feb 19, 2025 | |
| Buy | ALNYLAM PHARMACEUTICALS INC | Jan 29, 2025 | |
| Buy | ALNYLAM PHARMACEUTICALS INC | Jul 2, 2024 | |
| Sell | Alnylam Pharmaceuticals, Inc | Jan 29, 2024 | |
| Buy | Alnylam Pharmaceuticals, Inc | Jan 11, 2024 | |
| Sell | Alnylam Pharmaceuticals, Inc | Dec 11, 2023 |
This page tracks congressional stock trading activity in Alnylam Pharmaceuticals, Inc. (ALNY) in the Healthcare sector. Disclosed Capitol has indexed 36 disclosed congressional trades involving ALNY. Every trade is sourced from official STOCK Act financial disclosure filings — the same primary records the Senate and House are required to publish. The full trade list with politician names, transaction types, amount ranges, and disclosure dates is below, alongside cross-references to any related lobbying activity, federal contracts, and committee assignments.
As of June 2026 — Disclosed Capitol has tracked 36 disclosed congressional trades in Alnylam Pharmaceuticals, Inc. (ALNY) — 14:11 sell-heavy ratio — led by Ro Khanna (D).
| Date | Politician | Party | Action | Amount |
|---|---|---|---|---|
| 2026-05-15 | Michael McCaul | R | Sell | $15,001 - $50,000 |
| 2026-01-26 | Michael McCaul | R | Buy | $15,001 - $50,000 |
| 2025-10-30 | Michael McCaul | R | Sale | $50,001 - $100,000 |
| 2025-05-12 | Jefferson Shreve | R | Sale | $15,001 - $50,000 |
| 2025-02-19 | Ro Khanna | D | Purchase | $1,001 - $15,000 |
| 2025-01-29 | Ro Khanna | D | Purchase | $1,001 - $15,000 |
| 2024-07-02 | Ro Khanna | D | Purchase | $1,001 - $15,000 |
| 2024-01-29 | Josh Gottheimer | D | Sale | $1,001 - $15,000 |
| 2024-01-11 | Josh Gottheimer | D | Buy | $1,001 - $15,000 |
| 2023-12-11 | Josh Gottheimer | D | Sale | $1,001 - $15,000 |
Across the 36 disclosed congressional trades in Alnylam Pharmaceuticals, Inc. (ALNY), members of Congress have reported 11 buys and 14 sells. The average 30-day alpha vs. the S&P 500 is 2.06%.